NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift 
Spirit Airlines Shuts Down Flights, Issues Refunds After Financial Collapse 
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges 
United Airlines Flight Hits Light Pole During Newark Landing, FAA Investigates 
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth 
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight 
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue 
Middle East Conflict Impacts Australia and New Zealand Businesses 
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth 
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth 
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat 
TEANECK, N.J., May 07, 2018 -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on June 27, 2018, to stockholders of record at the close of business on June 6, 2018.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. For further information, please visit www.pahc.com.
Contact:
Richard Johnson
Chief Financial Officer, Phibro Animal Health Corporation
+1 201-329-7300
[email protected]
